News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest – and a clamor to know how soon it might be available. Talk turned ...

OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced the U.S. Food and Drug Administration ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Lawmakers grilled ...

Patients taking the weight-loss drug semaglutide were less likely to die from COVID-19, according to a recent study. The patients who contracted COVID-19 while using a weekly 2.4 mg dose of ...

We are living in an epidemic of chronic disease, with a growing number of pesticides, chemicals and food additives implicated in the declining health of Americans. Since 2019, another factor has been ...

It wasn’t that long ago that people considered Moderna and Pfizer to be saviors. Their work during the COVID-19 pandemic brought on an unusual outpouring of support and goodwill toward the ...

Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...

Researchers continue looking at existing medicine for help in the fight against the novel coronavirus, because those drugs already exist and could quickly make a big difference. The latest lead for ...

A common drug may be able to cure a common illness. Around 1 in 4 people have developed long-haul symptoms of COVID-19, experiencing fatigue, brain fog, chronic cough, chest pain and more for three ...

Moore Vogel is a long Covid patient-researcher at Scripps Research and the Patient Led Research Collaborative (PLRC). Charlie McCone is a long Covid patient advocate, is a member of the PLRC, and has ...